Kelch L, Wagner T, Grazikowske H
Z Gastroenterol. 1980 Nov;18(11):576-82.
In 10 female patients with carcinoma the effect of a single dose of 5-fluorouracil on morphologic alterations of the small bowel mucosa, intestinal disaccharidase-activities and lactose-tolerance-test was studied pre- and 96 hours posttherapy. After having given a standard dose of 1,25-1,50 gr 5-fluorouracil intravenously ( = 22 mg per kilo body weight) histologic changes of the small bowel mucosa (slight edema and shortening of the villi) were noted only in 4 cases. In the other cases the small intestine showed no morphological alterations of the mucosa. In all patients the lactose-tolerance-test after therapy with 5-fluorouracil was not affected. Following the administration of 5-fluorouracil no reduction of intestinal disaccharidase activities (maltase, saccharase, lactase) was observed. As a consequence of our results we suppose, that a patient given a single dose of 5-fluorouracil intravenously needs no specific diet without milk or milk-products.
对10例女性癌症患者,研究了静脉注射单剂量5-氟尿嘧啶前及治疗后96小时对小肠黏膜形态学改变、肠双糖酶活性及乳糖耐量试验的影响。静脉注射标准剂量1.25 - 1.50克5-氟尿嘧啶(=每公斤体重22毫克)后,仅4例出现小肠黏膜组织学改变(轻度水肿和绒毛缩短)。其他病例小肠黏膜未出现形态学改变。所有患者接受5-氟尿嘧啶治疗后的乳糖耐量试验未受影响。给予5-氟尿嘧啶后,未观察到肠双糖酶活性(麦芽糖酶、蔗糖酶、乳糖酶)降低。根据我们的结果,我们推测,静脉注射单剂量5-氟尿嘧啶的患者无需特殊饮食,无需避免食用牛奶或奶制品。